Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

InterHealth Responsible For Zychrome Claims By Manufacturers – NAD

This article was originally published in The Tan Sheet

Executive Summary

NAD recommends InterHealth discontinue superiority claims comparing its Zychrome chromium dinicocysteinate ingredient to Nutrition 21’s chromium picolinate product, Chromax. The decision tracks FTC’s position of holding branded ingredient suppliers responsible for claims made by their customers.

You may also be interested in...



In Brief

Sen. Hatch on path to re-election; Senate passes FDA Safety and Innovation Act; DSM petitions FDA for folic acid fortification of masa flour; Nutrition 21 returns under new management; ZO Skin Health defends trademarks; more news In Brief.

Retailer Training Crucial To Keeping Supplement Claims Compliant

Dietary supplement manufacturers bear the burden of ensuring businesses selling their products comply with claims regulations, experts say

People In Brief

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106363

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel